Gastric Cancer
Gastrointestinal Tract Tumors: A Current Multimodal Approach and Radiotherapy, NOVA Publications , ss.41-62, 2026
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2026
- Yayınevi: NOVA Publications
- Sayfa Sayıları: ss.41-62
- Anahtar Kelimeler: chemotherapy, gastric cancer, immunotherapy, multimodal therapy, radiotherapy, surgery, targeted therapy
- Recep Tayyip Erdoğan Üniversitesi Adresli: Evet
Özet
Gastric cancer, or stomach cancer, originates from the lining of the stomach and can develop slowly over years. Symptoms often include persistent stomach pain, difficulty swallowing, nausea, weight loss, and changes in appetite. Risk factors vary widely, including family history, infections such as Helicobacter pylori, dietary habits, and smoking. Treatment options depend on several factors, including the stage of the cancer and the patient’s general health status. Common multimodal approaches include: Surgery: Usually the primary treatment for localized cancer, it may involve partial (partial gastrectomy) or total stomach removal (total gastrectomy), sometimes accompanied by the removal of adjacent lymph nodes. Chemotherapy: Used before surgery to reduce tumor size (neoadjuvant) or after surgery to eliminate residual cells (adjuvant). Radiotherapy: Used in combination with chemotherapy or as palliative care to relieve symptoms in advanced cases. Targeted Therapy: Includes drugs that specifically target cancer cell mutations, aiming to minimize side effects compared to conventional chemotherapy. Immunotherapy: Enhances the immune system’s ability to fight cancer and is particularly effective for certain stomach cancers with specific biomarkers. Clinical Trials: Offer access to innovative treatments under investigation that may provide additional options for patients. Gastric cancer should be managed by a multidisciplinary team to offer patient-specific treatment approaches.